New eye drop trial targets debilitating dryness in autoimmune disease
NCT ID NCT07118241
Summary
This study is testing a new eye drop called rhPRG4 to see if it is safe and effective for treating dry eye disease in people with Sjögren's syndrome. It will involve about 80 adults in Australia who will use the eye drop or a placebo for 28 days. The main goal is to see if the treatment can completely heal damage to the surface of the eye and reduce uncomfortable symptoms like dryness, burning, and pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJÖGREN´S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
OTA
RECRUITINGBrisbane, Queensland, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Queensland University of Technology
RECRUITINGBrisbane, Queensland, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sydney Eye Hospital
NOT_YET_RECRUITINGSydney, New South Wales, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Univ of New South Wales
RECRUITINGSydney, New South Wales, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Melbourne
RECRUITINGMelbourne, Victoria, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of the Sunshine Coast
RECRUITINGMaroochydore, Queensland, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.